378 related articles for article (PubMed ID: 29435777)
21. Practical guidance on the use of laboratory testing in the management of bleeding in patients receiving direct oral anticoagulants.
Ten Cate H; Henskens YM; Lancé MD
Vasc Health Risk Manag; 2017; 13():457-467. PubMed ID: 29263674
[TBL] [Abstract][Full Text] [Related]
22. Identification of risk factors for inappropriate and suboptimal initiation of direct oral anticoagulants.
Howard M; Lipshutz A; Roess B; Hawes E; Deyo Z; Burkhart JI; Moll S; Shilliday BB
J Thromb Thrombolysis; 2017 Feb; 43(2):149-156. PubMed ID: 27757787
[TBL] [Abstract][Full Text] [Related]
23. Effect of gene polymorphims on the warfarin treatment at initial stage.
Liu J; Jiang HH; Wu DK; Zhou YX; Ye HM; Li X; Luo ZY; Guo Z; Zhang YL; Wang YC; Zhang W; Zhou HH; Wang LS
Pharmacogenomics J; 2017 Jan; 17(1):47-52. PubMed ID: 26644206
[TBL] [Abstract][Full Text] [Related]
24. Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.
Conway SE; Hwang AY; Ponte CD; Gums JG
Pharmacotherapy; 2017 Feb; 37(2):236-248. PubMed ID: 27983747
[TBL] [Abstract][Full Text] [Related]
25. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
26. Managing the perioperative patient on direct oral anticoagulants.
Leitch J; van Vlymen J
Can J Anaesth; 2017 Jun; 64(6):656-672. PubMed ID: 28429198
[TBL] [Abstract][Full Text] [Related]
27. 10 years of oral anticoagulant pharmacogenomics: what difference will it make? A critical appraisal.
Kurnik D; Loebstein R; Halkin H; Gak E; Almog S
Pharmacogenomics; 2009 Dec; 10(12):1955-65. PubMed ID: 19958094
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenomics and Personalized Medicine.
Cecchin E; Stocco G
Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
[TBL] [Abstract][Full Text] [Related]
29. Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.
Intagliata NM; Henry ZH; Maitland H; Shah NL; Argo CK; Northup PG; Caldwell SH
Dig Dis Sci; 2016 Jun; 61(6):1721-7. PubMed ID: 26725062
[TBL] [Abstract][Full Text] [Related]
30. New perspectives in personalised medicine for ethnicity in cancer: population pharmacogenomics and pharmacometrics.
Nair S; LLerena A
Drug Metab Pers Ther; 2018 Jun; 33(2):61-64. PubMed ID: 29688886
[No Abstract] [Full Text] [Related]
31. The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective.
Wood B; Nascimento B; Rizoli S; Sholzberg M; McFarlan A; Phillips A; Ackery AD
Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):76. PubMed ID: 28768548
[TBL] [Abstract][Full Text] [Related]
32. Pharmacogenomics and warfarin therapy.
Ndegwa S
Issues Emerg Health Technol; 2007 Oct; (104):1-8. PubMed ID: 17912794
[TBL] [Abstract][Full Text] [Related]
33. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
34. Assessing an oral surgery specific protocol for patients on direct oral anticoagulants: a retrospective controlled cohort study.
Lababidi E; Breik O; Savage J; Engelbrecht H; Kumar R; Crossley CW
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):940-946. PubMed ID: 29653869
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of direct oral anticoagulants during pregnancy; a systematic literature review.
Lameijer H; Aalberts JJJ; van Veldhuisen DJ; Meijer K; Pieper PG
Thromb Res; 2018 Sep; 169():123-127. PubMed ID: 30036784
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing for warfarin therapy initiation.
Hynicka LM; Cahoon WD; Bukaveckas BL
Ann Pharmacother; 2008 Sep; 42(9):1298-303. PubMed ID: 18682545
[TBL] [Abstract][Full Text] [Related]
37. Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissection.
Yoshio T; Tomida H; Iwasaki R; Horiuchi Y; Omae M; Ishiyama A; Hirasawa T; Yamamoto Y; Tsuchida T; Fujisaki J; Yamada T; Mita E; Ninomiya T; Michitaka K; Igarashi M
Dig Endosc; 2017 Sep; 29(6):686-694. PubMed ID: 28295638
[TBL] [Abstract][Full Text] [Related]
38. Current challenges and future prospects in oral anticoagulant therapy.
Czuprynska J; Patel JP; Arya R
Br J Haematol; 2017 Sep; 178(6):838-851. PubMed ID: 28573648
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation.
Jacobs V; May HT; Bair TL; Crandall BG; Cutler MJ; Day JD; Mallender C; Osborn JS; Stevens SM; Weiss JP; Woller SC; Bunch TJ
Am J Cardiol; 2016 Jul; 118(2):210-4. PubMed ID: 27236255
[TBL] [Abstract][Full Text] [Related]
40. Management of Direct-Acting Oral Anticoagulants Surrounding Dental Procedures With Low-to-Moderate Risk of Bleeding.
Lusk KA; Snoga JL; Benitez RM; Sarbacker GB
J Pharm Pract; 2018 Apr; 31(2):202-207. PubMed ID: 28506106
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]